Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)
- 6 June 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (2), 313-321
- https://doi.org/10.1016/j.amjcard.2005.03.065
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular RiskEuropean Urology, 2005
- RANDOMIZED STUDY OF TESTOSTERONE GEL AS ADJUNCTIVE THERAPY TO SILDENAFIL IN HYPOGONADAL MEN WITH ERECTILE DYSFUNCTION WHO DO NOT RESPOND TO SILDENAFIL ALONEJournal of Urology, 2004
- Clinical Evaluation and Management Strategy for Sexual Dysfunction in Men and WomenThe Journal of Sexual Medicine, 2004
- Evaluation of vardenafil and sildenafil on cardiac repolarizationThe American Journal of Cardiology, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gelThe Aging Male, 2003
- Overview of the cardiovascular effects of tadalafilEuropean Heart Journal Supplements, 2002
- Acute and Prolonged Effects of Sildenafil on Brachial Artery Flow-Mediated Dilatation in Type 2 DiabetesDiabetes Care, 2002
- Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly studyJournal of Epidemiology and Community Health, 2002
- Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panelThe American Journal of Cardiology, 2000